Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Irritability in Pediatric Disruptive Behavior Disorders
NCT02824627Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Jan 2017
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), disruptive mood dysregulation disorder (DMDD), sponsored by University of Nebraska. Started Jan 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
attention deficit hyperactivity disorder (ADHD)oppositional defiant disorder (ODD)conduct disorder (CD)disruptive mood dysregulation disorder (DMDD)
Beyond the preview
Go deeper on NCT02824627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824627.